4/A 1 form4a_090302.txt AMENDMENT NO. 1 TO FORM 4
---------------- U.S. SECURITIES AND EXCHANGE COMMISSION |F O R M 4| WASHINGTON, D.C. 20549 ---------------- [X] Check this box if no longer STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 (Print or Type Responses) ------------------------------------------------------------------------------------------------------------------------------------ |1.Name and Address of Reporting Person |2.Issuer Name and Ticker or Trading Symbol |6.Relationship of Reporting Persons to | | | | Issuer (Check all applicable) | | | | | | Meyer S. Lewis | Lipid Sciences, Inc. (LIPD) | X Director 10% Owner | |----------------------------------------|------------------------------------------------|--- --- | | (Last) (First) (Middle) |3.IRS or Identification|4.Statement for Month/ | Officer Other | | | Number of Reporting | Year |---(give title below) ---(specify below)| | | Person, | | | | | (Voluntary) | | | | 5232 Springridge Way | | August 2002 | | |----------------------------------------| |------------------------|----------------------------------------| | (Street) | |5.If Amendment, Date of |7. Individual or Joint/Group Filing | | | | Original (Month/Year) | (Check Applicable Line) | | | | | | | | | | X Form filed by One Reporting Person | | | | |--- | | | | | Form filed by More than One | | Fairfield, California 94585 | | |--- Reporting Person | |----------------------------------------------------------------------------------------------------------------------------------| | (City) (State) (Zip) | | TABLE I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | |----------------------------------------------------------------------------------------------------------------------------------| |1.Title of Security |2.Transac- |3.Trans- |4.Securities Acquired (A) or |5.Amount of |6.Owner- |7.Nature of | | (Instr. 3) | tion Date | action | Disposed of (D) | Securities | ship Form:| Indirect | | |(Month/Day/ | Code | (Instr. 3, 4 and 5) | Beneficially | Direct (D)| Beneficial | | | Year) | (Instr. 8) | | Owned at End | or | Ownership | | | |-------------|---------------------------------| of Month | Indirect | (Instr.4) | | | | | | Amount |(A) or | | (Instr. 3 & 4)| (I) | | | | | Code | V |(See Note 1) |(D) | Price | | (Instr. 4)| | |------------------------|------------|-------------|-------------|-------|-----------|----------------|------------|--------------| | | | | | | | | | | | | Common Stock | 08/05/02 | P | | 80,000 | A |$4.04/share| 80,000(8/14/02)| D | | ------------------------------------------------------------------------------------------------------------------------------------ Reminder: Report on a separate line for each class of securities owned directly or indirectly. (Over)
FORM 4 (continued) TABLE II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) ------------------------------------------------------------------------------------------------------------------------------------ |1.Title of|2.Conver-|3.Trans-|4.Trans- |5.Number of |6.Date |7.Title and |8.Price of|9.Number|10. |11.Nat-| |Derivative|sion or | action | action | Derivative | Exercisable | Amount |Derivative|of |Owner-|ure of | |Security |Exercise | Date | Code | Securities | and | of |Security |Deriv- |ship |Indi- | |(Instr. 3)|Price of |(Month/ |(Instr.8)| Acquired (A) or | Expiration | Underlying |(Instr. 5)|ative |Form |rect | | |Deriva- | Day/ | | Disposed of (D) | Date | Securities | |Securi- |of |Bene- | | |tive | Year) | | (Instr. 3, 4 and | (Month/Day/ | (Instr. | |ties |Deriv-|ficial | | |Security | | | 5) | Year) | 3 and 4) | |Bene- |ative |Owner- | | | | | | | | | |ficially|Secu- |ship | | | | | | | | | |Owned at|rity: |(Instr.| | | | | | | | | |End of |Direct|4) | | | | | | | | | |Month |(D) or| | | | | | | | | | |(Instr. |In- | | | | | | | | | | |4) |direct| | | | | | | |-----------------|-----------------| | |(I) | | | | | | | |Date |Expir- | |Amount or| | |(In- | | | | | |---------|-------------------|Exer- |ation | |Number of| | |str. | | | | | | | | | |cisable |Date | Title |Shares | | |4) | | |----------|---------|--------|-----|---|---------|---------|--------|--------|-------|---------|----------|--------|------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ----------------------------------------------------------------------------------------------------------------------------------- Explanation of Responses: Lipid Sciences, Inc. ** Intentional misstatements or omissions of facts constitute Federal By: /s/ S. Lewis Meyer 8/13/02 Criminal Violations. --------------------------- ----------------- Name: S. Lewis Meyer Date Title: Director See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure.